搜索优化
English
搜索
图片
视频
地图
资讯
购物
Copilot
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
4 小时
on MSN
New ‘wellness court’ for drug users launches Wednesday in Philadelphia, as police ...
The city on Wednesday will officially launch what it is calling a “neighborhood wellness court” in Kensington, an initiative ...
4 小时
Alberta government offers blueprint to help businesses support workers in recovery
The province and t Centre of Recovery Excellence released a document with ideas to help people dealing with addiction who are ...
4 小时
Why aren’t these booze stats keeping us awake at night?
Still, WHO said that worldwide alcohol consumption per capita had decreased from an average of 5.7 litres in 2010 to 5.5 ...
7 小时
on MSN
Sobering Up: Your Guide to Surviving Alcohol Withdrawal Without Losing Your Cool
Alcohol withdrawal can be managed safely with the right approach. By recognising symptoms early, seeking medical help, and ...
12 小时
Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says ...
A discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...
Daily Emerald
13 小时
How to Choose the Right Alcohol Rehab Center for Your Recovery Journey
Choosing the right alcohol rehab center can influence your recovery journey and enhance your chances of long-term sobriety.
17 小时
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults ...
Johnson & Johnson (NYSE: JNJ) announced today the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, making ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈